Publication | Open Access

Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase

ImmunohematologyAutoimmune DiseaseAnti-pd-1/pd-l1 AntibodyGranulocyteImmunologyHematologySclc PatientsInflammatory MarkerAutoimmunityEarly PhaseImmunological BiomarkersImmunotherapyMedicineHealth Sciences